tradingkey.logo

BUZZ-Nutriband rises as Noble Capital starts coverage with 'outperform'

ReutersJan 22, 2025 3:55 PM

** Shares of transdermal pharma products maker Nutriband NTRB.O rise ~28% to $6.67

** Brokerage Noble Capital starts coverage on NTRB with "outperform" rating and sets PT at $13

** PT represents a 148% upside to the stock's last

** NTRB is developing Aversa, a proprietary technology that makes transdermal patches safer by preventing abuse and misuse of potent opioids like fentanyl

** Brokerage says NTRB's tech has "abuse-deterrent" features that differentiate it from other transdermal patches on the market

** Also notes NTRB's partnership to add the Aversa technology to Kindeva's transdermal fentanyl patch could be a highly effective means to stop misuse

** NTRB shares doubled in 2024

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI